Oxcarbazepine and the HLA-A*3101 and HLA-B*1502 genes
As a result of genetic variations, your body may not produce certain proteins or may produce them with an abnormal composition, potentially changing the way in which drugs are processed.
It is known, for example, that mutations in the HLA-B*1502 gene can increase the risk of (serious) side effects. The role of the HLA-A*3101 gene is probably more limited.
Information about your genetic predisposition may therefore provide grounds for extra vigilance in relation to a treatment with oxcarbazepine.
Read more about HLA-A*3101 / HLA-B*1502 »